RS 17053 hydrochloride

Pricing Availability   Qty
说明: α1A antagonist
化学名: (N-[2-(2-Cyclopropylmethoxyphenoxy)ethyl]-5-chloro-α,α-dimethyl-1H-indole-3-ethanamine) hydrochloride
说明书
引用文献
评论
文献 (1)

生物活性 for RS 17053 hydrochloride

RS 17053 hydrochloride is an α1A-adrenoceptor antagonist, with very high affinity for α1A receptors (pKi and pA2 estimates of 9.1 - 9.9) and a 30 - 100 fold selectivity over the α1B and α1D subtypes (pKi and pA2 estimates 7.7 - 7.8).

许可信息

Sold with the permission of Roche Bioscience

技术数据 for RS 17053 hydrochloride

分子量 449.42
公式 C24H29N2O2Cl.HCl
储存 Store at RT
CAS Number 169505-93-5
PubChem ID 9824953
InChI Key QFOPFGRPNPCPBX-UHFFFAOYSA-N
Smiles Cl.CC(C)(CC1=CNC2=CC=C(Cl)C=C12)NCCOC1=C(OCC2CC2)C=CC=C1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for RS 17053 hydrochloride

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
ethanol 4.49 10
DMSO 22.47 50

制备储备液 for RS 17053 hydrochloride

以下数据基于产品分子量 449.42。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
0.5 mM 4.45 mL 22.25 mL 44.5 mL
2.5 mM 0.89 mL 4.45 mL 8.9 mL
5 mM 0.45 mL 2.23 mL 4.45 mL
25 mM 0.09 mL 0.45 mL 0.89 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for RS 17053 hydrochloride

参考文献 for RS 17053 hydrochloride

参考文献是支持产品生物活性的出版物。

Ford et al (1996) RS 17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-α,α-dimethyl-1H-indole-3-ethanamine hydrochloride, a selective α1A-adrenoceptor antagonist, displays low affinity for functional α1-adrenoceptors in huma Mol.Pharmacol. 49 209 PMID: 8632751

Marshall et al (1996) Different subtypes of α1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053. Br.J.Pharmacol. 119 407 PMID: 8886428

Ford et al (1995) Do α1A1C)-adrenoceptors (AR) mediate prostatic smooth muscle contraction in man? Studies with a novel, selective α1A-AR antagonist, RS 17053. Br.J.Pharmacol. 114 C25


If you know of a relevant reference for RS 17053 hydrochloride, please let us know.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Adrenergic α1 Receptor Antagonists

关键词: RS 17053 hydrochloride, RS 17053 hydrochloride supplier, α1A-adrenoceptor, alpha1A-adrenoceptor, α1-adrenergic, alpha1-adrenergic, a1-adrenoceptor, a1-adrenergic, antagonists, receptors, RS17053, hydrochloride, Adrenergic, Alpha-1, Receptors, 0985, Tocris Bioscience

篇 RS 17053 hydrochloride 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 RS 17053 hydrochloride 的引用文献。 您是否知道使用了 Tocris RS 17053 hydrochloride 的优秀论文? 请告知我们.

RS 17053 hydrochloride 的评论

目前没有该产品的评论。 Be the first to review RS 17053 hydrochloride and earn rewards!

Have you used RS 17053 hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.